Drug Shortage Report for DOCETAXEL INJECTION

Last updated on 2025-04-25

Report ID 249508
Drug Identification Number 02439336
Brand name DOCETAXEL INJECTION
Common or Proper name DOCETAXEL INJECTION
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) DOCETAXEL
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 16ML
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2025-02-20
Actual start date
Estimated end date 2025-04-30
Actual end date 2025-04-24
Shortage status Resolved
Updated date 2025-04-25
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-04-25 English Compare
v9 2025-04-24 English Compare
v8 2025-04-24 English Compare
v7 2025-04-24 French Compare
v6 2025-04-24 English Compare
v5 2025-02-21 English Compare
v4 2025-02-06 English Compare
v3 2025-02-03 French Compare
v2 2025-02-03 English Compare
v1 2025-02-03 English Compare

Showing 1 to 10 of 10